03/11/2020 - 12:25

$1.1m tax rebate booster for Proteomics coffers

03/11/2020 - 12:25

Bookmark

Save articles for future reference.

ASX-listed medical technology company, Proteomics International Laboratories’ coffers have been further boosted by a $1.1 million research and development tax rebate following a recent successful capital raise of $6 million. The Perth-based company, known for its predictive diagnostic tests, now has approximately $8.5 million in cash reserves including the funds from the share placement and the rebate of $1.13 million from the Australian Taxation Office.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options